Home/Filings/4/0001209191-13-023056
4//SEC Filing

SIMON NICHOLAS J III 4

Accession 0001209191-13-023056

CIK 0001428522other

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 1:56 PM ET

Size

12.3 KB

Accession

0001209191-13-023056

Insider Transaction Report

Form 4
Period: 2013-04-23
Transactions
  • Purchase

    Series B Convertible Preferred Stock

    2013-04-23$61.42/sh+91,175$5,599,9690 total(indirect: See footnote)
    Common Stock (911,750 underlying)
  • Purchase

    Common Stock Warrant

    2013-04-23$6.14/sh+227,939$1,400,0010 total(indirect: See footnote)
    Exercise: $6.14From: 2013-04-23Exp: 2018-04-23Common Stock (227,939 underlying)
Transactions
  • Purchase

    Series B Convertible Preferred Stock

    2013-04-23$61.42/sh+91,175$5,599,9690 total(indirect: See footnote)
    Common Stock (911,750 underlying)
  • Purchase

    Common Stock Warrant

    2013-04-23$6.14/sh+227,939$1,400,0010 total(indirect: See footnote)
    Exercise: $6.14From: 2013-04-23Exp: 2018-04-23Common Stock (227,939 underlying)
WHEELER KURT
10% Owner
Transactions
  • Purchase

    Series B Convertible Preferred Stock

    2013-04-23$61.42/sh+91,175$5,599,9690 total(indirect: See footnote)
    Common Stock (911,750 underlying)
  • Purchase

    Common Stock Warrant

    2013-04-23$6.14/sh+227,939$1,400,0010 total(indirect: See footnote)
    Exercise: $6.14From: 2013-04-23Exp: 2018-04-23Common Stock (227,939 underlying)
Footnotes (3)
  • [F1]Each share of Series B Convertible Preferred Stock has no expiration date and is convertible at any time, in whole or in part, at the election of the holder at a conversion rate of 10 shares of Common Stock for every 1 share of Series B Convertible Preferred Stock.
  • [F2]The shares are held as follows: 75,899 by MPM BioVentures III-QP, L.P. ("BV III QP"), 5,103 by MPM BioVentures III, L.P. ("BV III"), 1,468 by MPM Asset Management Investors 2003 BVIII LLC ("AM 2003"), 2,291 by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel") and 6,414 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"). MPM BioVentures III GP, L.P. ("MPM III GP") and MPM BioVentures III LLC ("MPM III LLC") are the direct and indirect general partners of BV III QP, BV III, BV Parallel and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz and Kurt Wheeler are the Series A members of MPM III LLC and the managers of AM 2003. Each reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his or its respective pecuniary interest therein.
  • [F3]The warrants are held as follows: 189,748 by BV III QP, 12,758 by BV III, 3,670 by AM 2003, 5,728 by BV Parallel and 16,035 by BV KG. Each reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his or its respective pecuniary interest therein.

Issuer

Radius Health, Inc.

CIK 0001428522

Entity typeother

Related Parties

1
  • filerCIK 0001221595

Filing Metadata

Form type
4
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 1:56 PM ET
Size
12.3 KB